<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04135482</url>
  </required_header>
  <id_info>
    <org_study_id>ZJU-JX-CD1</org_study_id>
    <nct_id>NCT04135482</nct_id>
  </id_info>
  <brief_title>CD Patients Immune Status Evaluation</brief_title>
  <official_title>Evaluating the Immune Status of Patients With Severe Crohn's Disease Using Single Cell Sequencing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital of Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Zhejiang University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using single cell sequencing method to evaluate and compare the immune status of patients
      with severe CD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 21, 2019</start_date>
  <completion_date type="Anticipated">July 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>single cell analysis of the colonic tissue of patients with severe crohn's disease</measure>
    <time_frame>1 year</time_frame>
    <description>single cell analysis of the colonic tissue of patients with severe crohn's disease: inflammed and non-inflammed area from right colon or the terminal ileum</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">7</enrollment>
  <condition>Severe Crohn's Diease</condition>
  <arm_group>
    <arm_group_label>CD</arm_group_label>
    <description>patients with severe crohn's disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>colonic tissue biopsy</intervention_name>
    <description>colonic tissue biospy of patients with severe crohn's disease using colonoscopy</description>
    <arm_group_label>CD</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Using the biospy samples of right colon or the last segment of ileum (both inflammation area
      and normal area nearby of 5cm), when patients receiving colonoscopy.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The patients were diagnosed as severe CD based on clinical, laboratory, endoscopic changes
        and imging.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: 1, Patients with severe CD（CDAI&gt;16,SES-CD&gt;19） 2, Patients have no
        previous any drug therapy targeting CD or just received treatment of 5-ASA - Exclusion
        Criteria: 1, patients have previous treatment of prednisone, immunosuppressive agents such
        as azathioprine and biologic agents such as infliximab 2, patients were diagnozed as
        mild-moderate CD 3, patients have other immune disordered diseases such as SLE, PBC, AIH,
        PSC, sjogren syndrome, ulcerative colitis, and so on.

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xi Jin, PhD</last_name>
    <phone>13867465085</phone>
    <email>jxfl007@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>The First Affiliated Hospital, School of Medicine, Zhejiang University</name>
      <address>
        <city>Hanzhou</city>
        <state>Zhe Jiang</state>
        <zip>310003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xi Jin, PhD</last_name>
      <phone>13867465085</phone>
      <email>jxfl007@zju.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 20, 2019</study_first_submitted>
  <study_first_submitted_qc>October 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2019</study_first_posted>
  <last_update_submitted>July 1, 2020</last_update_submitted>
  <last_update_submitted_qc>July 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>singcel cell sequencing</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

